Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers for immune checkpoint inhibition in sarcomas – are we close to clinical implementation?
Chin Sern Yiong, Tzu Ping Lin, Vivian Lim, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 17

Showing 17 citing articles:

Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application
Yuyuan Zhang, Mengjun Xu, Yuqing Ren, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 24
Immunotherapy in Sarcoma: Current Data and Promising Strategies
Georgina Wood, Christian F. Meyer, Florent Petitprez, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 7
Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma
Yan Peng, Jie Wang, Bin Yue, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189171-189171
Closed Access | Times Cited: 6
Impact of comprehensive genomic profiling on the diagnosis and clinical management of malignant mesenchymal tumours
Anna Beáta Csepregi, Eszter Papp, Imola Adamik, et al.
Pathology & Oncology Research (2025) Vol. 31
Open Access
Perioperative immunotherapy for esophageal squamous cell carcinoma
Dan D. Wei, Jin M. Fang, Huan Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
The importance of protein domain mutations in cancer therapy
Kiran Kumar Chitluri, Isaac Arnold Emerson
Heliyon (2024) Vol. 10, Iss. 6, pp. e27655-e27655
Open Access | Times Cited: 3
Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy
Di Chen, Lixia Xu, Mengjuan Xuan, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 9
Open Access | Times Cited: 3
Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer
Xing He, Yaorong Peng, Gui He, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 8
Immune pathway through endometriosis to ovarian cancer
Mariana Santos Calmon, Fabian Fellipe Bueno Lemos, Marcel Silva Luz, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 4, pp. 496-522
Open Access | Times Cited: 1
An ion channel-based prognostic model identified TRPV2 and GJB3 as immunotherapy determinants in pancreatic cancer
Jiakai Mao, Yu Tian, Nan Luo
Heliyon (2024) Vol. 10, Iss. 7, pp. e27301-e27301
Open Access | Times Cited: 1
Immunotherapy and Radiotherapy Combinations for Sarcoma
Qian S. Zhang, John P. Hayes, Vinai Gondi, et al.
Seminars in Radiation Oncology (2024) Vol. 34, Iss. 2, pp. 229-242
Closed Access | Times Cited: 1
Evaluation of the efficacy and safety of immunotherapy in sarcoma: a two-center study
Zhichao Liao, Jianjin Teng, Tao Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Distinct roles of CD244 expression in cancer diagnosis and prognosis: A pan-cancer analysis
Zhenzhen Deng, Yuanhong Liu, Haiyan Zhou
Heliyon (2024) Vol. 10, Iss. 7, pp. e28928-e28928
Open Access | Times Cited: 1
Deciphering the correlation between metabolic activity through 18F-FDG-PET/CT and immune landscape in soft-tissue sarcomas: an insight from the NEOSARCOMICS study
Amandine Crombé, Frédéric Bertolo, Lucile Vanhersecke, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access
Combination treatment with PD1/PDL-1 inhibitors for sarcomas: state of the art, next questions
Javier Martín‐Broto, Nadia Hindi, David S. Moura
Current Opinion in Oncology (2024) Vol. 36, Iss. 4, pp. 269-275
Closed Access
Qingfei mixture mitigates immunosuppression of tumor microenvironment in non-small cell lung cancer by blocking stat1/Ido1-mediated tryptophan-kynurenine pathway
Zhuo Chen, Yu-Heng Ding, Lan Shao, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e32260-e32260
Open Access
CD47 in Osteosarcoma: Correlation with Metastasis and Macrophage-Mediated Phagocytosis
Yunmi Ko, Seog-Yun Park, Jong Woong Park, et al.
Cells (2024) Vol. 13, Iss. 22, pp. 1862-1862
Open Access
Page 1

Scroll to top